Anemia of prematurity overview: Difference between revisions
| (6 intermediate revisions by the same user not shown) | |||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
[[Anemia of prematurity]] is a [[normochromic]], [[normocytic]] [[anemia]] commonly seen in [[premature birth|premature]] [[infant|infants]] cared for in the [[neonatal intensive care unit]]. Normally, all the [[newborn|newborns]] develop [[anemia]] during the first few weeks of their life after [[birth]]. Decreased [[erythropoietin]] production, increased [[erythropoietin]] metabolism, and shortened [[RBC]] lifespan leads to [[anemia]] in [[newborn|newborns]]. [[Term infants]] tolerate it well and do not require any [[treatments|treatment]]. This [[physiological anemia]] in [[newborn|newborns]] resolves with increasing age. Whereas, [[premature birth|premature]] infants develop [[anemia]] rapidly and more profoundly. [[Blood loss]] during [[phlebotomy]] and other illness related to [[prematurity]] contribute to the development of [[anemia of prematurity]]. Severity of [[symptom|symptoms]] varies with the blood [[hemoglobin]] levels. [[Treatments|Treatment]] involves [[blood transfusion]] and [[recombinant]] human [[erythropoietin]] [[therapy]]. | |||
==Historical perspective== | |||
==Classification== | |||
There is no established system for the classification of [[anemia of prematurity]]. | |||
==Pathophysiology== | ==Pathophysiology== | ||
[[Anemia of prematurity]] | [[Anemia of prematurity]] occurs as a result of a combination of increased [[blood loss]] or [[red blood cell]] destruction, decreased [[erythropoietin]] production, increased [[erythropoietin]] [[metabolism]], deficient [[iron]] stores, and decreased [[RBC]] lifespan. [[Phlebotomy]] is the major contributing factor of [[anemia of prematurity]]. [[Term]] [[infant|infants]] tolerate [[anemia]] well and do not develop any [[symptom|symptoms]] and resolve with increasing age. Whereas, in [[premature birth|preterm]] [[infant|infants]] these factors exaggerate to cause a severe form of [[anemia]] more rapidly. | ||
==Causes== | ==Causes== | ||
Common causes of [[anemia of prematurity]] include [[preterm birth]], [[blood loss]] during [[phlebotomy]], increased destruction of [[red blood cells]], and decreased production of [[red blood cells]]. [[Iron]], [[vitamin B6]], [[vitamin E]], and [[folate]] deficiencies are less common causes of [[anemia of prematurity]]. | Common causes of [[anemia of prematurity]] include [[preterm birth]], [[blood loss]] during [[phlebotomy]], increased destruction of [[red blood cells]], and decreased production of [[red blood cells]]. [[Iron]], [[vitamin B6]], [[vitamin E]], and [[folate]] deficiencies are less common causes of [[anemia of prematurity]]. | ||
==Differentiating Anemia of prematurity from other diseases== | |||
[[Anemia of prematurity]] should be differentiated from [[anemia]] due to increased [[red blood cell]] destruction, increased [[blood loss]], and decreased [[red blood cell]] production. It should also be differentiated from other causes of [[normocytic]] [[normochromic]] anemia. | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
[[Anemia of prematurity]] is a common problem in [[neonatal intensive care unit]] [[(NICU)]]. It usually affects [[preterm]] and [[low birth weight]] [[infants]] born before 32-weeks of [[gestation]]. The risk of [[anemia of prematurity]] is inversely proportional to [[birth weight]] and [[gestational age]] at time of birth. | ===Age=== | ||
[[Anemia of prematurity]] is a common problem in [[neonatal intensive care unit]] [[(NICU)]]. It usually affects [[preterm]] and [[low birth weight]] [[infants]] born before 32-weeks of [[gestation]]. The risk of [[anemia of prematurity]] is inversely proportional to [[birth weight]] and [[gestational age]] at time of birth. | |||
===Gender=== | |||
Men and women are equally likely to develop [[anemia of prematurity]] | |||
===Race=== | |||
There is no racial predilection for [[anemia of prematurity]] | |||
==Risk factors== | ==Risk factors== | ||
| Line 43: | Line 58: | ||
==Treatment== | ==Treatment== | ||
===Medical Therapy=== | ===Medical Therapy=== | ||
[[ | [[Blood transfusion]] is the mainstay in the [[treatments|treatment]] of [[anemia of prematurity]]. [[Treatments|Treatment]] of [[infant|infants]] with [[anemia of prematurity]] depends on the severity of [[symptom|symptoms]]. [[Asymptomatic]] [[patient|patients]] are managed with [[close monitoring]] and [[supportive care]]. Whereas, [[blood transfusion]] and [[recombinant]] [[erythropoietin]] [[therapy]] are required to [[treat]] [[infant|infants]] with symptomatic [[anemia of prematurity]]. | ||
===Primary Prevention=== | ===Primary Prevention=== | ||
Effective measures for the [[primary prevention]] of [[anemia of prematurity]] include limiting [[blood loss]] during [[phlebotomy]], [[cord blood]] sampling for the [[laboratory investigations]], and improving [[placental transfusion]]. | Effective measures for the [[primary prevention]] of [[anemia of prematurity]] include limiting [[blood loss]] during [[phlebotomy]], [[cord blood]] sampling for the [[laboratory investigations]], and improving [[placental transfusion]]. | ||
===Secondary Prevention=== | |||
There are no established measures for the secondary prevention of [[anemia of prematurity]]. | |||
==References== | ==References== | ||
Latest revision as of 09:48, 12 August 2020
|
Anemia of prematurity Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Anemia of prematurity overview On the Web |
|
American Roentgen Ray Society Images of Anemia of prematurity overview |
|
Risk calculators and risk factors for Anemia of prematurity overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Asra Firdous, M.B.B.S.[2]
Overview
Anemia of prematurity is a normochromic, normocytic anemia commonly seen in premature infants cared for in the neonatal intensive care unit. Normally, all the newborns develop anemia during the first few weeks of their life after birth. Decreased erythropoietin production, increased erythropoietin metabolism, and shortened RBC lifespan leads to anemia in newborns. Term infants tolerate it well and do not require any treatment. This physiological anemia in newborns resolves with increasing age. Whereas, premature infants develop anemia rapidly and more profoundly. Blood loss during phlebotomy and other illness related to prematurity contribute to the development of anemia of prematurity. Severity of symptoms varies with the blood hemoglobin levels. Treatment involves blood transfusion and recombinant human erythropoietin therapy.
Historical perspective
Classification
There is no established system for the classification of anemia of prematurity.
Pathophysiology
Anemia of prematurity occurs as a result of a combination of increased blood loss or red blood cell destruction, decreased erythropoietin production, increased erythropoietin metabolism, deficient iron stores, and decreased RBC lifespan. Phlebotomy is the major contributing factor of anemia of prematurity. Term infants tolerate anemia well and do not develop any symptoms and resolve with increasing age. Whereas, in preterm infants these factors exaggerate to cause a severe form of anemia more rapidly.
Causes
Common causes of anemia of prematurity include preterm birth, blood loss during phlebotomy, increased destruction of red blood cells, and decreased production of red blood cells. Iron, vitamin B6, vitamin E, and folate deficiencies are less common causes of anemia of prematurity.
Differentiating Anemia of prematurity from other diseases
Anemia of prematurity should be differentiated from anemia due to increased red blood cell destruction, increased blood loss, and decreased red blood cell production. It should also be differentiated from other causes of normocytic normochromic anemia.
Epidemiology and Demographics
Age
Anemia of prematurity is a common problem in neonatal intensive care unit (NICU). It usually affects preterm and low birth weight infants born before 32-weeks of gestation. The risk of anemia of prematurity is inversely proportional to birth weight and gestational age at time of birth.
Gender
Men and women are equally likely to develop anemia of prematurity
Race
There is no racial predilection for anemia of prematurity
Risk factors
Anemia of prematurity is a serious problem in preterm infants. Common risk factors in the development of anemia of prematurity are preterm birth, low birth weight, and excess blood loss during phlebotomy. Less common risk factors are family history of anemia, anemia and nutritional deficiencies in mother during pregnancy, multiple gestations, complications during pregnancy and delivery, blood loss during pregnancy and delivery, and twin-to-twin transfusion.
Natural History, Complications, and Prognosis
Anemia of prematurity can be asymptomatic or produce abnormal clinical signs and symptoms depending on the hemoglobin levels. Mild symptoms usually resolve spontaneously without treatment. Severe symptoms require treatment with blood transfusion and erythropoietin. Untreated anemia of prematurity can lead to poor growth, apnea, and cardiovascular instability. The prognosis of anemia of prematurity is good with prompt diagnosis and early treatment.
Diagnosis
History and Symptoms
Majority of patients with anemia of prematurity are either asymptomatic or develop vague and non-specific symptoms. They usually present with pallor and lethargy. Decreased activity, breathing difficulties, feeding difficulties, and difficulty in gaining weight are common symptoms. Less common symptoms are tachycardia, heart murmurs, and metabolic acidosis.
Physical Examination
Patients with anemia of prematurity usually appear pale and lethargic. Physical examination of patients with anemia of prematurity is usually remarkable for pallor, decreased activity, and poor growth.
Laboratory Findings
Laboratory findings consistent with the diagnosis of anemia of prematuriy are reduced hemoglobin, hematocrit, and reticulocyte count in the blood. Normocytic, normochromic RBCs and red blood cell precursors are seen predominantly on the peripheral smear of patients with anemia of prematurity.
Ultrasound
There are no ultrasound findings associated with anemia of prematurity. Cranial USG and abdominal USG can be done to exclude other causes of anemia.
Other Imaging Findings
There are no other imaging findings associated with anemia of prematurity.
Other Diagnostic Studies
There are no other diagnostic studies associated with anemia of prematurity.
Treatment
Medical Therapy
Blood transfusion is the mainstay in the treatment of anemia of prematurity. Treatment of infants with anemia of prematurity depends on the severity of symptoms. Asymptomatic patients are managed with close monitoring and supportive care. Whereas, blood transfusion and recombinant erythropoietin therapy are required to treat infants with symptomatic anemia of prematurity.
Primary Prevention
Effective measures for the primary prevention of anemia of prematurity include limiting blood loss during phlebotomy, cord blood sampling for the laboratory investigations, and improving placental transfusion.
Secondary Prevention
There are no established measures for the secondary prevention of anemia of prematurity.